Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01835275 · ClinicalTrials.gov registry record · NA

Audio-enhanced Analgesia in Healthy Subjects

A NA study of Healthy, sponsored by Massachusetts General Hospital.

Completed
Registry status
NA
Development phase
60
Enrollment target
1
Study location

NCT01835275: Completed NA study of Healthy, sponsored by Massachusetts General Hospital.

NCT01835275 is a NA study of Healthy that has completed, run by Massachusetts General Hospital. The registered enrollment target is 60 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT01835275, a NA study of Healthy, has completed, sponsored by Massachusetts General Hospital.

COMPLETED
Registry status
NA
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to determine whether enhanced audio methods can be used to improve analgesia for experimental pain in healthy subjects.

Primary Outcome

0-100 Visual Analog Scales to rate subjective pain intensity and unpleasentness

Conditions Studied

Interventions

  • BEHAVIORAL Enhanced Audio
  • BEHAVIORAL Audio

Study Locations (1)

Massachusetts

  • Department of Psychiatry, Mass General Hospital - Charlestown

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2012-06
Est. Completion 2013-04
Phase NA
Massachusetts General Hospital

2,032 total trials

What the finished NCT01835275 record still lists

NCT01835275 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (91% lower).

The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 2 interventions - of which Enhanced Audio is the first listed.

NCT01835275 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT01835275 about?

NCT01835275 is a clinical study titled "Audio-enhanced Analgesia in Healthy Subjects". The purpose of this study is to determine whether enhanced audio methods can be used to improve analgesia for experimental pain in healthy subjects.

What is the current status of trial NCT01835275?

This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2012-06. Estimated completion is 2013-04.

What conditions does trial NCT01835275 study?

This clinical trial studies the following conditions: Healthy.

What interventions are being tested in trial NCT01835275?

The interventions under investigation include: Enhanced Audio (BEHAVIORAL), Audio (BEHAVIORAL).

Who is sponsoring clinical trial NCT01835275?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01835275 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01835275's enrollment target sits among peer trials

60 369th of 1090 higher than 689 of 1,090 other Healthy trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Healthy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00576069 · 60 participants

    Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma

  • NCT01297400 · 60 participants · Phase 2

    Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns

  • NCT01734122 · 60 participants

    Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor

  • NCT01804634 · 60 participants · Phase 2

    Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01835275, the US trial registry maintained by the National Library of Medicine. NCT01835275 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.